Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole

Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer

NCT01151215 ·Status: TERMINATED ·Phase: PHASE2

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer

NCT00078832 ·Status: COMPLETED ·Phase: PHASE3

Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer

NCT00077025 ·Status: COMPLETED ·Phase: PHASE2

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

NCT00544986 ·Status: COMPLETED ·Phase: PHASE4

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

NCT00256698 ·Status: COMPLETED ·Phase: PHASE3

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

NCT00291759 ·Status: COMPLETED ·Phase: PHASE3

Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.

NCT00921115 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer

NCT00330317 ·Status: COMPLETED ·Phase: PHASE3

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

NCT00295646 ·Status: COMPLETED ·Phase: PHASE3

Neoadjuvant Hormonal Treatment of Postmenopausal Women Who Have Operable Breast Cancer

NCT00437853 ·Status: COMPLETED ·Phase: NA

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

NCT00638391 ·Status: COMPLETED

Patient's Anastrozole Compliance to Therapy Programme

NCT00555867 ·Status: TERMINATED

Efficacy of Anastrozole and Fulvestrant in Patients With ER Positive, HER2 Negative, Operable Breast Cancer

NCT00629616 ·Status: COMPLETED ·Phase: PHASE2

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

NCT00329940 ·Status: COMPLETED ·Phase: PHASE3

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

NCT00871858 ·Status: COMPLETED ·Phase: PHASE2

Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects

NCT01183832 ·Status: COMPLETED

Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole

NCT00543127 ·Status: TERMINATED ·Phase: PHASE3

Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer

NCT00688909 ·Status: COMPLETED ·Phase: PHASE4

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

NCT04294225 ·Status: COMPLETED ·Phase: PHASE2

Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer

NCT00248170 ·Status: COMPLETED ·Phase: PHASE3

Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not

NCT01553903 ·Status: COMPLETED ·Phase: PHASE4

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

NCT01953588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant

NCT02374099 ·Status: TERMINATED ·Phase: PHASE2

Treatment of Locally Advanced Breast Cancer With Letrozole in Postmenopausal Women

NCT00237133 ·Status: COMPLETED ·Phase: PHASE4

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

NCT00291798 ·Status: COMPLETED ·Phase: PHASE2